CompletedNot Applicable

Effects of Aerobic Thai Dance in Patient With Diabetic Peripheral Neuropathy

Thailand44 participantsStarted 2022-09-19

Plain-language summary

The goal of this type of study is clinical trial. This to learn about effects of applied aerobic Thai dance exercise on gait balance and sudomotor function in patient with diabetic peripheral neuropathy. Test variables of gait, balance, function of sudomotor, Physiological data such as pulse, blood pressure, body composition, ankle and leg muscle strength, compare with control and experimental group in diabetes with peripheral neuropathy. The main question Question 1: Dose Applied aerobic Thai dance exercise affects gait and balance in diabetic patients with peripheral neuropathy? Question 2: Does applied aerobic Thai dance exercise affect sudomotor function in diabetic patients with peripheral neuropathy? Participants will divided into 2 groups: the control group and the experimental group. By randomly sampling 22 people from each group 1. The control group was advised to exercise at home for a period of 12 weeks. 2. The experimental group participated in Applied aerobic Thai dance exercise 60 minutes per session, 3 times per week, for a period of 12 weeks. After 12 weeks, variable data were collected and to compare within and between groups.

Who can participate

Age range

60 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with type 2 diabetes between the ages of 60 and 75. * The BMI index is between 18.5 - 29.9 kg/m2. * MNSI score between 2.5 - 7.5 points. * There were no exercise-related complications from the PAR -Q assessment. * Light to moderate level of physical activity. * Not being a person with severe optic neuropathy (Severe-NPDR and Severe-PDR). * No wounds or infections on the feet. * No musculoskeletal abnormalities. * Not being a Pacemaker Implantation Person, No History of Heart Failure, Evaluated New York Heart Association Classification (NYHA) not over Functional Class II, If CAD must be treated, No history of Atrial Fibrillation severely wrong. * The doctor did not have a plan to adjust the medication in the last 3 months. Exclusion Criteria: * MNSI score greater than or equal to 8 points or more. * Participants lacked more than 20 percent of their exercise program. * Participants had foot ulcers and infections during the experiment. * Vitamins B1, 6 and 12 were taken during the trial. * The subject withdrew from the experiment.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Gait Speed

Timeframe: Baseline and 12 weeks

Step length

Timeframe: Baseline and 12 weeks

Single Support

Timeframe: Baseline and 12 weeks

Double Support

Timeframe: Baseline and 12 weeks

Cadence

Timeframe: Baseline and 12 weeks

Postural Stability Testing

Timeframe: Baseline and 12 weeks

Modified Clinical Test of Sensory Interaction in Balance (M-CTSIB)

Timeframe: Baseline and 12 weeks

Limits of Stability (LOS)

Timeframe: Baseline and 12 weeks

Trial details

NCT IDNCT06061237

SponsorChulalongkorn University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-10-20

View on ClinicalTrials.gov More Exercise Addiction trials

Plain-language summary

Who can participate

Age range

60 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Gait Speed

Timeframe: Baseline and 12 weeks

Step length

Timeframe: Baseline and 12 weeks

Single Support

Timeframe: Baseline and 12 weeks

Double Support

Timeframe: Baseline and 12 weeks

Cadence

Timeframe: Baseline and 12 weeks

Postural Stability Testing

Timeframe: Baseline and 12 weeks

Modified Clinical Test of Sensory Interaction in Balance (M-CTSIB)

Timeframe: Baseline and 12 weeks

Limits of Stability (LOS)

Timeframe: Baseline and 12 weeks